Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infection Asymptomatic”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Study completedNCT00848211
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects

Who this might be right for
HIV Infections
Thymon, LLC 24
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Not applicableStudy completedNCT00002048
What this trial is testing

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Who this might be right for
Lymphatic DiseaseHIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00002079
What this trial is testing

Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)

Who this might be right for
HIV Infections
G D Searle
Testing effectiveness (Phase 2)Study completedNCT00002357
What this trial is testing

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

Who this might be right for
HIV Infections
Hoechst Marion Roussel 144
Testing effectiveness (Phase 2)Study completedNCT00348673
What this trial is testing

A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061

Who this might be right for
HIV-1
Pfizer 49
Testing effectiveness (Phase 2)Study completedNCT00495677
What this trial is testing

PF-00232798 In HIV Positive Patients

Who this might be right for
HIV
Pfizer 43
Large-scale testing (Phase 3)Study completedNCT00002109
What this trial is testing

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

Who this might be right for
HIV Infections
Immunobiology Research Institute
Not applicableStudy completedNCT00841360
What this trial is testing

ID and Testing Via Friendship Networks

Who this might be right for
Asymptomatic HIVHIV Infections
University of North Carolina, Chapel Hill 535
Not applicableEnded earlyNCT02839603
What this trial is testing

Asymptomatic Leishmania Infection in HIV Patients

Who this might be right for
Visceral Leishmaniasis
Institute of Tropical Medicine, Belgium 540
Testing effectiveness (Phase 2)Study completedNCT00002324
What this trial is testing

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

Who this might be right for
HIV Infections
Boehringer Ingelheim 250
Not applicableStudy completedNCT00001997
What this trial is testing

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

Who this might be right for
HIV Infections
Chiron Corporation
Not applicableEnded earlyNCT02898896
What this trial is testing

Coronary Artery Disease (CAD) in Suppressed HIV-infected

Who this might be right for
Virus-HIV
University Hospital, Montpellier 62
Not applicableLooking for participantsNCT07312266
What this trial is testing

Questioning the Epidemiology of Asymptomatic TB

Who this might be right for
TuberculosisTuberculosis (TB)HIV+1 more
Barcelona Institute for Global Health 6,770
Testing effectiveness (Phase 2)Study completedNCT00001045
What this trial is testing

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)UnknownNCT01067417
What this trial is testing

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

Who this might be right for
HIV Infections
Medical Research Council 83
Testing effectiveness (Phase 2)Ended earlyNCT04840199
What this trial is testing

Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.

Who this might be right for
HIV InfectionsCytomegalovirusCMV
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)Study completedNCT00002078
What this trial is testing

Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection

Who this might be right for
HIV Infections
Purdue Frederick
Post-approval studies (Phase 4)Study completedNCT00002179
What this trial is testing

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 200
Next Page